DEFERIPRONE | N021825 | CHIESI USA INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Cooley's Anemia Foundation (CAF) FDA-2020-P-0421 The Cooley's Anemia Foundation filed this citizen petition under 21 U.S.C. § 355(q) requesting that the FDA require all deferiprone products, including generic versions, to implement monitoring and patient support measures comparable to ApoPharma's current voluntary REMS program for Ferriprox to ens | 505(q) | 2020-01-27 | Open | Cooley's Anemia Foundation (CAF) |
Source: Regulations.gov. FDA citizen petitions matched by application number.
| Code | Date | Status |
|---|---|---|
| ODE-417 | Apr 30, 2028 | Active |
| ODE-420 | Apr 30, 2028 | Active |
| ODE-421 | Apr 30, 2028 | Active |